This report contains market size and forecasts of Bevacizumab Injection in global, including the following market information:
Global Bevacizumab Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bevacizumab Injection Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Bevacizumab Injection companies in 2021 (%)
The global Bevacizumab Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
100mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bevacizumab Injection include Pfizer, Roche, Eli Lilly, Genentech, Bayer, Amgen, Samsung Bioepis, Centus and Cadila Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bevacizumab Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bevacizumab Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Bevacizumab Injection Market Segment Percentages, by Type, 2021 (%)
100mg
400mg
Global Bevacizumab Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Bevacizumab Injection Market Segment Percentages, by Application, 2021 (%)
Age-related macular degeneration (AMD)
Ovarian Cancer
Others
Global Bevacizumab Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Bevacizumab Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bevacizumab Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bevacizumab Injection revenues share in global market, 2021 (%)
Key companies Bevacizumab Injection sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Bevacizumab Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Eli Lilly
Genentech
Bayer
Amgen
Samsung Bioepis
Centus
Cadila Pharmaceuticals
Dr Reddy's
Mylan
Hetero Group
Biocon